CURE vs. UDOW
CURE (Direxion Daily Healthcare Bull 3x Shares) and UDOW (ProShares UltraPro Dow30) are both Leveraged Equities funds - CURE tracks the Health Care Select Sector Index (300%) while UDOW tracks the Dow Jones Industrial Average (300%). Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs 23.82%/yr for UDOW. A 0.71 correlation means they provide meaningful diversification when combined. CURE charges 1.08%/yr vs 0.95%/yr for UDOW.
Performance
CURE vs. UDOW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -7.96% return, which is significantly lower than UDOW's 14.65% return. Over the past 10 years, CURE has underperformed UDOW with an annualized return of 13.49%, while UDOW has yielded a comparatively higher 23.82% annualized return.
CURE
- 1D
- -0.55%
- 1M
- 13.53%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 26.46%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
UDOW
- 1D
- 2.07%
- 1M
- 8.49%
- YTD
- 14.65%
- 6M
- 11.42%
- 1Y
- 51.98%
- 3Y*
- 32.31%
- 5Y*
- 13.79%
- 10Y*
- 23.82%
CURE vs. UDOW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
UDOW ProShares UltraPro Dow30 | 14.65% | 24.46% | 28.47% | 32.72% | -32.39% | 65.67% | -17.15% | 75.24% | -23.86% | 99.07% |
Correlation
The correlation between CURE and UDOW is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.63 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.71 |
The correlation between CURE and UDOW shifts across timeframes, from 0.51 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.
CURE vs. UDOW - Sectors Allocation Comparison
Sectors
CURE
UDOW
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
CURE
UDOW
Basic Materials
CURE
-
UDOW
Communication Services
CURE
-
UDOW
Consumer Cyclical
CURE
-
UDOW
Consumer Defensive
CURE
-
UDOW
Energy
CURE
-
UDOW
Financial Services
CURE
-
UDOW
Industrials
CURE
-
UDOW
Real Estate
CURE
-
UDOW
-
Technology
CURE
-
UDOW
Utilities
CURE
-
UDOW
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. UDOW — Risk / Return Rank
CURE
UDOW
CURE vs. UDOW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares UltraPro Dow30 (UDOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | UDOW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.80 | ||
| Sortino ratioReturn per unit of downside risk | -0.81 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.24 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.85 | 1.86 | -1.01 |
| Martin ratioReturn relative to average drawdown | 1.94 | 6.59 | -4.65 |
Loading charts...
Drawdowns
CURE vs. UDOW - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UDOW drawdown of -80.29%. Use the drawdown chart below to compare losses from any high point for CURE and UDOW.
Loading charts...
Drawdown Indicators
| CURE | UDOW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -80.29% | +11.10% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -28.07% | -3.03% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -44.83% | -7.10% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -55.79% | +3.56% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -80.29% | +11.10% |
Current DrawdownCurrent decline from peak | -26.94% | -2.65% | -24.29% |
Average DrawdownAverage peak-to-trough decline | -18.16% | -14.37% | -3.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.71% | 7.94% | +5.77% |
Volatility
CURE vs. UDOW - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to ProShares UltraPro Dow30 (UDOW) at 12.92%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than UDOW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | UDOW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.30% | 12.92% | +1.38% |
Volatility (6M)Calculated over the trailing 6-month period | 30.87% | 29.12% | +1.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.32% | 37.38% | +6.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.84% | 44.39% | -0.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.59% | 51.84% | -2.25% |
CURE vs. UDOW - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than UDOW's 0.95% expense ratio.
Dividends
CURE vs. UDOW - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.16%, less than UDOW's 1.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
UDOW ProShares UltraPro Dow30 | 1.18% | 1.38% | 0.95% | 0.95% | 0.83% | 0.26% | 0.19% | 0.61% | 0.73% | 0.13% | 0.26% | 0.21% |
Frequently Asked Questions
CURE and UDOW have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to UDOW (12.92%). In terms of maximum drawdown, CURE dropped -69.19% vs UDOW's -80.29%.
On 10-year performance, UDOW leads with 23.82% vs 13.49% for CURE. On fees, UDOW is cheaper at 0.95% per year. On volatility, UDOW has been the lower-risk option at 12.92%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UDOW has performed better with a 23.82% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UDOW is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
UDOW has the higher dividend yield at 1.18%, compared with 1.16% for CURE.
CURE tracks Health Care Select Sector Index (300%), while UDOW tracks Dow Jones Industrial Average (300%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for UDOW.
UDOW currently has the higher Sharpe Ratio (1.40 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and UDOW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer